Neulasta and Intestinal obstruction - a phase IV clinical study of FDA data
Summary:
Intestinal obstruction is reported as a side effect among people who take Neulasta (pegfilgrastim), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ondansetron, and have Non-hodgkin's lymphoma.
The phase IV clinical study analyzes which people have Intestinal obstruction when taking Neulasta. It is created by eHealthMe based on reports of 92,148 people who have side effects when taking Neulasta from the FDA, and is updated regularly.
What is Neulasta?
Neulasta has active ingredients of pegfilgrastim. It is often used in agranulocytosis. eHealthMe is studying from 92,286 Neulasta users. Check the latest studies of Neulasta.
What is Intestinal obstruction?
Intestinal obstruction is found to be associated with 1,887 drugs and 2,613 conditions by eHealthMe. Check the latest studies of Intestinal obstruction.
92,148 people reported to have side effects when taking Neulasta.
Among them, 105 people (0.11%) have Intestinal obstruction.
Among these 105 people:
How long have people been on Neulasta when they have Intestinal obstruction? *
What is the gender of people who have Intestinal obstruction when taking Neulasta? *
What is the age of people who have Intestinal obstruction when taking Neulasta? *
What are other drugs people take besides Neulasta? *
What are other side effects people have besides Intestinal obstruction? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Neulasta and have Intestinal obstruction?
- Check whether Intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Neulasta:
- Neulasta (92,286 reports)
Intestinal obstruction treatments and more:
- Intestinal obstruction (59,346 reports)
How severe was Intestinal obstruction and when was it recovered:
Expand to all the drugs that have ingredients of pegfilgrastim:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Neulasta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Intestinal obstruction:
- Intestinal obstruction (1,887 drugs)
Browse all the conditions that are associated with Intestinal obstruction:
- Intestinal obstruction (2,613 conditions)
Related publications that referenced our studies
- Khan A, Yasin Z, "Hyperleukocytosis Caused By Neulasta Complicated By Leukostasis Versus Asymptomatic Uncomplicated Hyperleukocytosis In AML. Two Cases and When To Leukapherese.", Am Soc Hematology, 2017 Jan .
- Khan A, Yasin Z, "Hyperleukocytosis Caused By Neulasta Complicated By Leukostasis Versus Asymptomatic Uncomplicated Hyperleukocytosis In AML. Two Cases and When To Leukapherese.", Am Soc Hematology, 2017 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on pegfilgrastim (the active ingredients of Neulasta) and Neulasta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fludara and Chills for Women aged 60+ - now
- Drug interactions of Rythmol and Zithromax - 2 seconds ago
- Norvasc and Singultus for Women aged 60+ - 2 seconds ago
- Norvasc and Hiccups for Women aged 60+ - 2 seconds ago
- Could Aubagio cause Paranasal Sinus Discomfort? - 3 seconds ago
- Could Zmax cause Nausea And Vomiting? - 4 seconds ago
- Lemtrada and Dyspnoea for Men aged 40-49 - 5 seconds ago
- Lemtrada and Dyspnea for Men aged 40-49 - 5 seconds ago
- Drug interactions of Cyanocobalamin and Gammagard - 5 seconds ago
- Lorazepam and Not Effective for Men aged 30-39 - 8 seconds ago